Aquatic Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,428
Closed -$130K 1753
2025
Q4
$130K Buy
12,428
+1,385
+13% +$13.9K ﹤0.01% 1105
2025
Q3
$99.3K Buy
11,043
+7,366
+200% +$64.6K ﹤0.01% 1214
2025
Q2
$47.8K Buy
3,677
+1,934
+111% +$29.1K ﹤0.01% 1145
2025
Q1
$44K Sell
1,743
-27,542
-94% -$818K ﹤0.01% 1144
2024
Q4
$1.01M Buy
29,285
+885
+3% +$39.9K 0.03% 541
2024
Q3
$1.4M Buy
28,400
+20,300
+251% +$1.04M 0.04% 439
2024
Q2
$487K Buy
+8,100
New +$463K 0.02% 546
2023
Q4
Sell
-1,300
Closed -$36K 1587
2023
Q3
$36K Buy
+1,300
New +$38.8K ﹤0.01% 1005

Other funds holding RXST

Aquatic Capital Management's RXST Position: Q1 2026 in Review

Aquatic Capital Management sold out of RxSight (RXST) in Q1 2026, closing a stake of 12,428 shares — an estimated $130K sold.

Aquatic Capital Management first reported a position in RXST in Q3 2023 and held it in 8 quarters. The position peaked at $1.4M in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Aquatic Capital Management reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 12,428 RxSight shares in Q1 2026, an estimated $130K.
  • Aquatic Capital Management first reported a position in RxSight in Q3 2023 and held it in 8 quarters.
  • Aquatic Capital Management's RxSight position peaked at $1.4M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.